Literature DB >> 2484182

Lubrication of selected salivary molecules and artificial salivas.

A Aguirre, B Mendoza, M S Reddy, F A Scannapieco, M J Levine, M N Hatton.   

Abstract

The lubrication regime displayed by human salivas (parotid and submandibular-sublingual), purified salivary molecules (the mucins MG1 and MG2 and alpha-amylases), and selected artificial salivas (Oracare D, Saliva Substitute, and Orthana) was assessed in vitro using a friction-testing device. Thin-film (boundary) lubrication was observed for all of the salivary samples and two of the artificial salivas examined. Oracare D, a glycerol-based artificial saliva, was the exception since it lubricated by a thick-film (hydrodynamic) regime. On a molar basis, the best lubricants of the purified salivary molecules were MG1 greater than MG2 approximately nonglycosylated alpha-amylases approximately glycosylated alpha-amylases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484182     DOI: 10.1007/bf02407152

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  17 in total

1.  In vitro characterization of human salivary lubrication.

Authors:  A Aguirre; B Mendoza; M J Levine; M N Hatton; W H Douglas
Journal:  Arch Oral Biol       Date:  1989       Impact factor: 2.633

Review 2.  Biochemistry of human alpha amylase isoenzymes.

Authors:  J J Zakowski; D E Bruns
Journal:  Crit Rev Clin Lab Sci       Date:  1985       Impact factor: 6.250

3.  Adsorption of human salivary mucins to hydroxyapatite.

Authors:  L A Tabak; M J Levine; N K Jain; A R Bryan; R E Cohen; L D Monte; S Zawacki; G H Nancollas; A Slomiany; B L Slomiany
Journal:  Arch Oral Biol       Date:  1985       Impact factor: 2.633

4.  Characterization of salivary alpha-amylase binding to Streptococcus sanguis.

Authors:  F A Scannapieco; E J Bergey; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Lubrication and viscosity features of human saliva and commercially available saliva substitutes.

Authors:  M N Hatton; M J Levine; J E Margarone; A Aguirre
Journal:  J Oral Maxillofac Surg       Date:  1987-06       Impact factor: 1.895

6.  Artificial salivas: present and future.

Authors:  M J Levine; A Aguirre; M N Hatton; L A Tabak
Journal:  J Dent Res       Date:  1987-02       Impact factor: 6.116

Review 7.  Role of salivary mucins in the protection of the oral cavity.

Authors:  L A Tabak; M J Levine; I D Mandel; S A Ellison
Journal:  J Oral Pathol       Date:  1982-02

8.  The lubricating activity of synovial fluid glycoproteins.

Authors:  D A Swann; R B Hendren; E L Radin; S L Sotman; E A Duda
Journal:  Arthritis Rheum       Date:  1981-01

9.  The binding of human salivary alpha-amylase by oral strains of streptococcal bacteria.

Authors:  C W Douglas
Journal:  Arch Oral Biol       Date:  1983       Impact factor: 2.633

10.  Characterization of in vivo salivary-derived enamel pellicle.

Authors:  I Al-Hashimi; M J Levine
Journal:  Arch Oral Biol       Date:  1989       Impact factor: 2.633

View more
  4 in total

1.  Large-scale purification and characterization of the major phosphoproteins and mucins of human submandibular-sublingual saliva.

Authors:  N Ramasubbu; M S Reddy; E J Bergey; G G Haraszthy; S D Soni; M J Levine
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  In-situ hybridization localized MUC7 mucin gene expression to the mucous acinar cells of human and MUC7-transgenic mouse salivary glands.

Authors:  S H Khan; A Aguirre; L A Bobek
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

Review 3.  Saliva substitutes for the treatment of radiation-induced xerostomia--a review.

Authors:  Sebastian Hahnel; Michael Behr; Gerhard Handel; Ralf Bürgers
Journal:  Support Care Cancer       Date:  2009-06-04       Impact factor: 3.603

4.  Chemokine expression of oral fibroblasts and epithelial cells in response to artificial saliva.

Authors:  Heinz-Dieter Müller; Barbara Cvikl; Adrian Lussi; Reinhard Gruber
Journal:  Clin Oral Investig       Date:  2015-09-05       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.